Skip to content
10-K

Annual Report

GLOBUS MEDICAL, INC. GMED

0001562762-25-000026

← back to feed
Filed
Feb 20, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 18, 2025 137.54M sh
Current Liabilities FY 2024 · Dec 31, 2023 $392.35M
Total Liabilities FY 2024 · Dec 31, 2023 $1.09B
Current Assets FY 2024 · Dec 31, 2023 $1.92B
Total Assets FY 2024 · Dec 31, 2023 $5.09B
Shares Diluted FY 2024 · Dec 31, 2022 102.64M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $144.49M
Capex FY 2024 · Dec 31, 2022 $74.05M
Operating Cash Flow FY 2024 · Dec 31, 2022 $178.47M
Eps Diluted FY 2024 · Dec 31, 2022 $1.85
Eps Basic FY 2024 · Dec 31, 2022 $1.89
Sga Expense FY 2024 · Dec 31, 2022 $432.12M
Rd Expense FY 2024 · Dec 31, 2022 $73.02M
Net Income FY 2024 · Dec 31, 2022 $190.17M
Operating Income FY 2024 · Dec 31, 2022 $227.95M
Cost Of Revenue FY 2024 · Dec 31, 2022 $263.73M
Revenue FY 2024 · Dec 31, 2022 $1.02B
Stockholders Equity FY 2024 · Dec 31, 2021 $1.74B